MALLORY LYNCH: Open Payments
NPI 1720508120 · BRANDENBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 28 payments from 15 companies in 2025. Trend: 2023 $1,051 · 2024 $460 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 4 | $89 |
| Amgen Inc. | 4 | $63 |
| Novo Nordisk Inc | 3 | $56 |
| Lilly USA, LLC | 3 | $52 |
| Corcept Therapeutics | 2 | $48 |
| PFIZER INC. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| ABBVIE INC. | 1 | $21 |
Products named: VOQUEZNA, JARDIANCE, REPATHA, Korlym, Ozempic, PAXLOVID, GEMTESA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
